Many pharmaceutical compounds can disrupt cardiac ion channels that control how the heart beats and functions, making drug-induced cardiotoxicity a significant challenge in drug development. Identifying these effects early requires sensitive methods capable of monitoring electrophysiological activity in real time. However, traditional electrophysiology techniques are often technically challenging, time-consuming, and difficult to scale.
This compendium explores how advanced optical electrophysiology technology supports rapid, reproducible analysis of cardiac function in both 2D and 3D cardiomyocyte models, providing deeper insight into cardiac safety and pharmacological responses.
Access this compendium to learn:
- Why precise ion channel analysis is essential for improving drug safety
- How optical scanning provides real-time, high throughput cardiac electrophysiology data
- How scalable optical scanning accelerates cardiac safety assessments and drug screening
